Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cara Therapeutics (CARA)

Cara Therapeutics (CARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Cara: Q2 Earnings Snapshot

Cara: Q2 Earnings Snapshot

CARA : 0.3087 (+7.94%)
Cara: Q1 Earnings Snapshot

Cara: Q1 Earnings Snapshot

CARA : 0.3087 (+7.94%)
Cara: Q4 Earnings Snapshot

Cara: Q4 Earnings Snapshot

CARA : 0.3087 (+7.94%)
Mira Pharmaceuticals Stock Is Soaring In November... Here's Why

Leveraging a favorable DEA classification for its synthetic analog of THC, Mira Pharmaceuticals could be on an expedited pathway toward commercialization to treat several unmet neurological m

MIRA : 1.1600 (-0.85%)
CARA : 0.3087 (+7.94%)
CRBP : 51.70 (+4.80%)
HRMY : 38.99 (+1.70%)
JAZZ : 111.29 (+1.57%)
Cara: Q3 Earnings Snapshot

Cara: Q3 Earnings Snapshot

CARA : 0.3087 (+7.94%)
Cara: Q2 Earnings Snapshot

Cara: Q2 Earnings Snapshot

CARA : 0.3087 (+7.94%)
Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus

/CNW/ -- Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that England's National Institute for...

CARA : 0.3087 (+7.94%)
Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus

/PRNewswire/ -- Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that England's National Institute...

CARA : 0.3087 (+7.94%)
Cara: Q1 Earnings Snapshot

Cara: Q1 Earnings Snapshot

CARA : 0.3087 (+7.94%)
Stocks Slide After the Fed Chairman Powell Warns Rates Will Likely Be Higher

Morning Markets The S&P 500 Index ( $SPX ) ( SPY ) today is down -0.41%, the Dow Jones Industrials Index ( $DOWI ) ( DIA ) is down -0.46%, and the Nasdaq 100 Index ( $IUXX ) ( QQQ ) is down -0.25%. Stock...

ESZ24 : 5,769.25 (-0.15%)
NQZ24 : 20,050.25 (-0.19%)
META : 559.10 (+3.93%)
DKS : 215.43 (+1.34%)
UAL : 52.59 (-0.70%)
TCOM : 47.44 (+1.58%)
SQSP : 46.42 (+0.02%)
DISH : 5.77 (+1.94%)
NTNX : 58.99 (+2.77%)
RIVN : 13.15 (+1.94%)
KEY : 17.34 (+4.52%)
ZYXI : 8.33 (+1.83%)

Barchart Exclusives

Talen Energy - Nuclear. Fossil, Solar And Coal All In One Package
Summary Talen Energy (TLN) shows strong technical indicators with 100% buy signals, a 247.38+ Weighted Alpha, and a 218.06% gain in the last year. The company operates 10.7 GW of power infrastructure, including nuclear, fossil, solar, and coal plants, and is developing battery storage projects. Wall Street analysts are bullish... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar